Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey (EDUCOVID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04732858
Recruitment Status : Active, not recruiting
First Posted : February 1, 2021
Last Update Posted : February 9, 2021
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:
The coronavirus disease 2019 (COVID-19) pandemic required a rapid surge of healthcare capacity to face a growing number of critically ill patients. For this reason, a support reserve of physicians, including surgeons, were required to be reassigned to offer support. Given the time shortage for trainers and trainees, time and cost-efficient programs to gain maximal benefit from short rotations for several physicians at one time are required 8. In case of pandemics, blending face-to-face education to e-learning seems sustainable, with online resources being scalable and more cost effective than other methods 9.

Condition or disease Intervention/treatment
COVID-19 Other: Cross sectional e-Survey on surgeons exposed to any educational intervention

Detailed Description:
The aim of this study was to realize a survey on the educational programs (hospital based or web-based), during the COVID-19 pandemic, and their impact on behavior change, satisfaction and knowledge of the target population of surgeons.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Educational Interventions to Integrate Surgical Staff Within Medical Units During the COVID-19 Pandemic: EDUCOVID Cross-sectional, E-survey
Actual Study Start Date : March 1, 2020
Actual Primary Completion Date : August 31, 2020
Estimated Study Completion Date : June 1, 2021



Intervention Details:
  • Other: Cross sectional e-Survey on surgeons exposed to any educational intervention

    Educational intervention was considered as any procedure or program to facilitate the acquisition of basic skills about the disease, its ramifications and treatment2,6,7:

    • Education in infectious disease, including

      • "pandemic" training for health personnel
      • Personal protective equipment (PPE) and protection.
      • Specific speed-training focusing on environmental control (decontamination area, dressing...), personal protection, hand hygiene, sample management, risky gestures, control measures.
    • Intensive care education:

      • mechanical ventilation
      • airways management
      • emergencies and cardiovascular drugs
      • Intensive care monitoring systems
    • Basic nurse skills
    • COVID-specific clinical management


Primary Outcome Measures :
  1. Kirkpatrick level 3 on a 5-modalities Likert scale [ Time Frame: once at the time of survey ]
    The primary endpoint of the e-survey was to explore the effectiveness of educational interventions experienced by responders, considered as a whole "bundle" (and not one-by-one), among the surgeons exposed to a training program, on behavior change (Kirkpatrick level 3) in their daily role during their re-affectation within a medical COVID-unit. Behavior change represents a change in the daily role of healthcare professionals (for example, referral of patients with suspected COVID to the most appropriate screening and care pathway). For this survey, we considered subjective measures (self-assessment on a Likert scale on 5 modalities) of behavior change.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
This survey was conceived as open to residents, fellows, consultants and physicians of any grade and affiliated to any surgical specialty.
Criteria

Inclusion Criteria:

  • residents, fellows, consultants and physicians of any grade and affiliated to any surgical specialty

Exclusion Criteria:

  • Mecical speciality

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04732858


Locations
Layout table for location information
France
Assistance Publique Hôpitaux de Paris - GHU AP-HP Hôpitaux Universitaires Henri-Mondor
Créteil, France, 94010
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Layout table for investigator information
Principal Investigator: Raffaele BRUSTIA, MD,PhD Assistance Publique - Hôpitaux de Paris
Layout table for additonal information
Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT04732858    
Other Study ID Numbers: APHP201297
First Posted: February 1, 2021    Key Record Dates
Last Update Posted: February 9, 2021
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Assistance Publique - Hôpitaux de Paris:
2019-nCoV
COVID-19
Pandemic
Educational intervention
Medical education
Additional relevant MeSH terms:
Layout table for MeSH terms
COVID-19
Respiratory Tract Infections
Infections
Pneumonia, Viral
Pneumonia
Virus Diseases
Coronavirus Infections
Coronaviridae Infections
Nidovirales Infections
RNA Virus Infections
Lung Diseases
Respiratory Tract Diseases